630 related articles for article (PubMed ID: 18388994)
1. Immunochemical studies and genetic background of two Neisseria meningitidis isolates expressing unusual capsule polysaccharide antigens with specificities of both serogroup Y and W135.
Tsang RS; Tsai CM; Henderson AM; Tyler S; Law DK; Zollinger W; Jamieson F
Can J Microbiol; 2008 Mar; 54(3):229-34. PubMed ID: 18388994
[TBL] [Abstract][Full Text] [Related]
2. Amino acid 310 determines the donor substrate specificity of serogroup W-135 and Y capsule polymerases of Neisseria meningitidis.
Claus H; Stummeyer K; Batzilla J; Mühlenhoff M; Vogel U
Mol Microbiol; 2009 Feb; 71(4):960-71. PubMed ID: 19170877
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001.
Tsang RS; Squires SG; Tam TW
Can J Microbiol; 2003 Oct; 49(10):633-8. PubMed ID: 14663497
[TBL] [Abstract][Full Text] [Related]
4. Molecular surveillance of Neisseria meningitidis capsular switching in Portugal, 2002-2006.
Simões MJ; Cunha M; Almeida F; Furtado C; Brum L
Epidemiol Infect; 2009 Feb; 137(2):161-5. PubMed ID: 18667108
[TBL] [Abstract][Full Text] [Related]
5. Rapid and fatal meningococcal disease due to a strain of Neisseria meningitidis containing the capsule null locus.
Hoang LM; Thomas E; Tyler S; Pollard AJ; Stephens G; Gustafson L; McNabb A; Pocock I; Tsang R; Tan R
Clin Infect Dis; 2005 Mar; 40(5):e38-42. PubMed ID: 15714405
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the meningococcal serogroup X capsule N-acetylglucosamine-1-phosphotransferase.
Muindi KM; McCarthy PC; Wang T; Vionnet J; Battistel M; Jankowska E; Vann WF
Glycobiology; 2014 Feb; 24(2):139-49. PubMed ID: 24134880
[TBL] [Abstract][Full Text] [Related]
7. Serological specificities of murine hybridoma monoclonal antibodies against Neisseria meningitidis serogroups B, C, Y, and W135 and evaluation of their usefulness as serogrouping reagents by indirect whole-cell enzyme-linked immunosorbent assay.
Tsang RS; Zollinger WD
Clin Diagn Lab Immunol; 2005 Jan; 12(1):152-6. PubMed ID: 15643000
[TBL] [Abstract][Full Text] [Related]
8. [Molecular characters of epidemic cerebrospinal W135 Neisseria meningitidis strain firstly isolated in Guangdong province].
Guan DW; Deng XL; Liu MZ; Ke BX; Zhang WL; Liang H; Liang J; Yang XF
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jan; 43(1):14-8. PubMed ID: 19534873
[TBL] [Abstract][Full Text] [Related]
9. [Neisseria meningitidis: characterisation and epidemiology].
Raymond J
Arch Pediatr; 2012 Sep; 19 Suppl 2():S55-60. PubMed ID: 22883367
[TBL] [Abstract][Full Text] [Related]
10. Genetic analysis of Canadian isolates of C:2a:P1.2,5 and B:2a:P1.2,5 Neisseria meningitidis strains belonging to the hypervirulent clone of ET-15.
Tyler S; Tsang R
Can J Microbiol; 2004 Jun; 50(6):433-43. PubMed ID: 15284889
[TBL] [Abstract][Full Text] [Related]
11. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.
Ceyhan M; Yildirim I; Balmer P; Riley C; Laher G; Andrews N; Borrow R; Kurt N; Turgut M; Aydogan A; Ecevit C; Uysal G; Schultze V
Vaccine; 2007 Oct; 25(41):7233-7. PubMed ID: 17707957
[TBL] [Abstract][Full Text] [Related]
12. Genetic mechanisms for loss of encapsulation in polysialyltransferase-gene-positive meningococci isolated from healthy carriers.
Weber MV; Claus H; Maiden MC; Frosch M; Vogel U
Int J Med Microbiol; 2006 Nov; 296(7):475-84. PubMed ID: 16876478
[TBL] [Abstract][Full Text] [Related]
13. Molecular characteristics of Neisseria meningitidis strains isolated in Burkina Faso in 2001.
Ouedraogo-Traore R; Høiby EA; Sanou I; Sangare L; Kyelem N; Ye-Ouattara D; Frøholm LO; Caugant DA
Scand J Infect Dis; 2002; 34(11):804-7. PubMed ID: 12578146
[TBL] [Abstract][Full Text] [Related]
14. Three cases of invasive meningococcal disease caused by a capsule null locus strain circulating among healthy carriers in Burkina Faso.
Findlow H; Vogel U; Mueller JE; Curry A; Njanpop-Lafourcade BM; Claus H; Gray SJ; Yaro S; Traoré Y; Sangaré L; Nicolas P; Gessner BD; Borrow R
J Infect Dis; 2007 Apr; 195(7):1071-7. PubMed ID: 17330799
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11 clone in Southern Brazil.
Weidlich L; Baethgen LF; Mayer LW; Moraes C; Klein CC; Nunes LS; Rios Sda S; Kmetzsch CI; Rossetti ML; Zaha A
J Infect; 2008 Oct; 57(4):324-31. PubMed ID: 18814914
[TBL] [Abstract][Full Text] [Related]
16. Latex agglutination for bacterial antigens and meningococcus PCR: two useful tools in legal sudden deaths.
Fernández-Rodríguez A; Vázquez JA; Suárez-Mier MP; Aguilera B; Ballesteros S; De la Fuente L; Vallejo G; Sancho M
Forensic Sci Int; 2005 Jan; 147(1):13-20. PubMed ID: 15541586
[TBL] [Abstract][Full Text] [Related]
17. Antigenic diversity of Neisseria meningitidis isolated in Taiwan between 1995 and 2002.
Yang CY; Lee YS; Huang LS; Kuo YL; Liu YL; Lu CH
Scand J Infect Dis; 2006; 38(4):273-80. PubMed ID: 16709528
[TBL] [Abstract][Full Text] [Related]
18. Four monoclonal antibodies against capsular polysaccharides of Neisseria meningitidis serogroups A, C, Y and W135: its application in identity tests.
Reyes F; Amin N; Otero O; Aguilar A; Cuello M; Valdés Y; García LG; Cardoso D; Camacho F
Biologicals; 2013 Jul; 41(4):275-8. PubMed ID: 23791517
[TBL] [Abstract][Full Text] [Related]
19. Elaboration of both the group W135 and group Y capsular polysccharides by a single strain of Neisseria meningitidis.
Brandt BL; Pier GB; Goroff DK; Altieri PL; Griffiss JM
J Gen Microbiol; 1980 May; 118(1):39-43. PubMed ID: 6775049
[TBL] [Abstract][Full Text] [Related]
20. Invasive potential of nonencapsulated disease isolates of Neisseria meningitidis.
Johswich KO; Zhou J; Law DK; St Michael F; McCaw SE; Jamieson FB; Cox AD; Tsang RS; Gray-Owen SD
Infect Immun; 2012 Jul; 80(7):2346-53. PubMed ID: 22508859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
